Literature DB >> 24615060

Pharmacokinetics study of asperosaponin VI and its metabolites cauloside A, HN saponin F and hederagenin.

Er-Wei Liu1, Jia-Long Wang, Li-Feng Han, Yan-Xu Chang, Tao Wang, Yan Huo, Lei Wang, Xiu-Mei Gao.   

Abstract

This experiment's with aim was to study the pharmacokinetics of asperosaponin VI and its three metabolites (cauloside A, HN saponin F and hederagenin) via a sensitive high performance liquid chromatography connected with electrospray ionization triple quadrupole mass spectrum (HPLC-ESI-MS/MS). Chromatographic separation was achieved on a reverse phase C18 column with a gradient mobile phase of CH3CN-water with 0.1 % HCOOH at a flow rate of 0.3 mL/min. Sample analysis was simultaneously performed with a multiple reaction monitoring mode using target determination ions at m/z 927.5 → 603.4 for asperosaponin VI, m/z 811.1 → 603.4 for cauloside A, m/z 649.4 → 603.4 for HN saponin F, m/z 71.4 → 393.3 for hederagenin and m/z 307.0 → 161.1 for warfarin as the internal standard. The calibration curve was linear at the range of 0.25-500 ng/mL, and the lower limit of quantification was 0.25 ng/mL for each compound. While the precisely intra-assay and inter-assay variabilities were <9.5 and 7.8 %, respectively; accuracy was determined at the concentrations of 5, 25, 100 ng/mL for all the analytes with the relative standard deviation (%) no more than 15.0 %. Consequently, the validated method could be successfully and precisely applied to the pharmacokinetic study of asperosaponin VI and its metabolites. As a result, the pharmacokinetic parameters of cauloside A, HN saponin F and hederagenin such as T max were obtained at 9.33 ± 2.49, 7.33 ± 0.47 and 12.33 ± 2.36 h, respectively.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24615060     DOI: 10.1007/s11418-014-0821-4

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  18 in total

1.  Biologically active triterpene saponins from callus tissue of Polygala amarella.

Authors:  S Desbène; B Hanquet; Y Shoyama; H Wagner; M A Lacaille-Dubois
Journal:  J Nat Prod       Date:  1999-06       Impact factor: 4.050

2.  Cells from rat marrow: sensitivity to effects of certain pentacyclic triterpenoids.

Authors:  M M Anisimov; N G Prokofieva; L I Strigina; N S Chetyrina; N G Aladina; G B Elyakov
Journal:  Biochem Pharmacol       Date:  1977-11-15       Impact factor: 5.858

3.  Anti-inflammatory activities of hederagenin and crude saponin isolated from Sapindus mukorossi Gaertn.

Authors:  K Takagi; E H Park; H Kato
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980       Impact factor: 1.645

4.  Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathways.

Authors:  Chunmei Li; Jingwei Tian; Guisheng Li; Wanglin Jiang; Yanli Xing; Jian Hou; Haibo Zhu; Hong Xu; Guanbo Zhang; Zhifeng Liu; Zuguang Ye
Journal:  Eur J Pharmacol       Date:  2010-09-20       Impact factor: 4.432

5.  [Chemical constituents of Dipsacus asper].

Authors:  Zi-Gang Yang; Kun Ding; Gang Xu; Yong Shen; Zhen-Gui Meng; Sheng-Chao Yang
Journal:  Zhong Yao Cai       Date:  2012-11

6.  In vitro anticomplementary activity of hederagenin saponins isolated from roots of Dipsacus asper.

Authors:  S R Oh; K Y Jung; K H Son; S H Park; I S Lee; K S Ahn; H K Lee
Journal:  Arch Pharm Res       Date:  1999-06       Impact factor: 4.946

7.  Inhibition of mouse ear edema by steroidal and triterpenoid saponins.

Authors:  S Y Kim; K H Son; H W Chang; S S Kang; H P Kim
Journal:  Arch Pharm Res       Date:  1999-06       Impact factor: 4.946

8.  Determination of asperosaponin VI in dog plasma by high-performance liquid chromatography-tandem mass spectrometry and its application to a pilot pharmacokinetic study.

Authors:  Shailendra Shakya; He Zhu; Li Ding; Xiao Lang Du; Xie Min Qi; Xiao Lin Yang; Zhong Lin Yang
Journal:  Biomed Chromatogr       Date:  2011-04-05       Impact factor: 1.902

9.  Determination of asperosaponin VI in rat plasma by HPLC-ESI-MS and its application to preliminary pharmacokinetic studies.

Authors:  Kai Li; Li Ding; Zhong-Lin Yang; E-Hu Liu; Lian-Wen Qi; Ping Li; Yu-Zhu Hu
Journal:  Biomed Chromatogr       Date:  2010-05       Impact factor: 1.902

10.  Apoptosis-inducing effect of akebia saponin D from the roots of Dipsacus asper Wall in U937 cells.

Authors:  Seung-Il Jeong; Beng Zhou; Jin-Beom Bae; Nam-Seok Kim; Sun-Geun Kim; Jin Kwon; Dae-Keun Kim; Tae-Yong Shin; Hoon Jeon; Jong-Phil Lim; Hongjun Kim; Ho Kyoung Kim; Chan-Ho Oh
Journal:  Arch Pharm Res       Date:  2008-11-21       Impact factor: 4.946

View more
  2 in total

1.  Pharmacokinetics, Bioavailability, Excretion and Metabolism Studies of Akebia Saponin D in Rats: Causes of the Ultra-Low Oral Bioavailability and Metabolic Pathway.

Authors:  Pengfei Li; Jun Peng; Yuexin Li; Lili Gong; Yali Lv; He Liu; Tianhong Zhang; Song Yang; Hongchuan Liu; Jinglai Li; Lihong Liu
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

Review 2.  Current knowledge and development of hederagenin as a promising medicinal agent: a comprehensive review.

Authors:  Jia Zeng; Ting Huang; Man Xue; Jianxing Chen; Linglin Feng; Ruofei Du; Yi Feng
Journal:  RSC Adv       Date:  2018-07-03       Impact factor: 4.036

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.